AP NEWS
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Bausch Health Announces Participation In Upcoming Investor Conferences

February 4, 2020 GMT
Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)
Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

LAVAL, Quebec, Feb. 4, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in three investor conferences.

Paul S. Herendeen, executive vice president and chief financial officer, Sam Eldessouky, senior vice president and corporate controller, and William Woodfield, vice president and treasurer, are scheduled to participate at the J.P. Morgan Global High Yield & Leveraged Finance Conference in Miami on Feb. 24, 2020 at 2:00 p.m. ET.

Paul S. Herendeen, executive vice president and chief financial officer, Sam Eldessouky, senior vice president and corporate controller, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Cowen & Co. 40th Annual Health Care Conference in Boston on March 3, 2020 at 8:40 a.m. ET.

Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Barclays Global Healthcare Conference 2020 in Miami on March 10 at 11:45 a.m. EDT.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com

lainie.keller@bauschhealth.com

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


View original content to download multimedia: http://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-300998184.html

SOURCE Bausch Health Companies Inc.